Cannabinoid modulation of cortical adrenergic receptors and transporters

Journal of Neuroscience Research

Volumn 87, Issue 16, 2009, Pages 3671-3678

  Reyes, Beverly A S ^a   Rosario, J C ^a   Piana, P M T ^a   Van Bockstaele, E J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

2 adrenergic receptor; 1 adrenergic receptor; Cannabinoid receptor; Norepinephrine transporter; WIN 55,212

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA 2 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; CANNABINOID 1 RECEPTOR; NORADRENALIN TRANSPORTER;

ABSTINENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; ATTENTION; CARBOXY TERMINAL SEQUENCE; COGNITION; CONTROLLED STUDY; DRUG ACTIVITY; FRONTAL CORTEX; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MICRODISSECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; WESTERN BLOTTING;

ANIMALS; BENZOXAZINES; BLOTTING, WESTERN; CANNABINOIDS; DRUG ADMINISTRATION SCHEDULE; FLUORESCENT ANTIBODY TECHNIQUE; FRONTAL LOBE; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MICROSCOPY, CONFOCAL; MORPHOLINES; NAPHTHALENES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, CANNABINOID;

EID: 71249161121     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22158     Document Type: Article

References (43)

1. Acquas E, Pisanu A, Marrocu P, Di Chiara G. 2000. Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol 401:179-185. (Pubitemid 30488194)
2. Arnsten AF. 2000. Through the looking glass: differential noradenergic modulation of prefrontal cortical function. Neural Plast 7:133-146.
3. Arnsten AF. 2007. Catecholamine and second messenger influences on prefrontal cortical networks of "representational knowledge": a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 17(Suppl 1):15-16.
4. Aston-Jones G, Foote SL, Bloom FE. 1984. Anatomy and physiology of locus coeruleus neurons: functional implications. In: Ziegler M, Lake CR, editors. Norepinephrine (Frontiers of Clinical Neuroscience). Baltimore: Williams and Wilkins. p 92-116.
5. Aston-Jones G, Rajkowski J, Cohen J. 1999. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46:1309-1320. (Pubitemid 30114448)
6. Bajo M, Roberto M, Schweitzer P. 2008. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands. J Neurosci Res 87:766-775
7. Bonisch H, Bruss M. 1994. The noradrenaline transporter of the neuronal plasma membrane. Ann N Y Acad Sci 733:193-202.
8. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, Threlkeld PG, Heiligenstein JH, Morin SM, Gehlert DR, Perry KW. 2002. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27:699-711.
9. D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E. 2008a. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of delta-9-tetrahydrocannabinol in humans. Psychopharmacology 198:587-603.
10. D'Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, Perry E, Krystal J. 2008b. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology 33:2505-2516.
11. Egertova M, Elphick MR. 2000. Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol 422:159-171. (Pubitemid 30390161)
12. Ghrebi SS, Owen GR, Brunette DM. 2007. Triton X-100 pretreatment of LR-white thin sections improves immunofluorescence specificity and intensity. Microsc Res Techniq 70:555-562.
13. Hofmann ME, Nahir B, Frazier CJ. 2008. Excitatory afferents to CA3 pyramidal cells display differential sensitivity to CB1 dependent inhibition of synaptic transmission. Neuropharmacology 55:1140-1146.
14. Lapiz MD, Morilak DA. 2006. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability. Neuroscience 137:1039-1049.
15. Le Moal M, Simon H. 1991. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155-234.
16. Lopez-Sendon J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. 2004. Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 25:1341-1362.
17. Malone DT, Taylor DA. 1999. Modulation by fluoxetine of striatal dopamine release following Delta9-tetrahydrocannabinol: a microdialysis study in conscious rats. Br J Pharmacol 128:21-26. (Pubitemid 29425263)
18. Marsicano G, Lutz B. 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11:4213-4225. (Pubitemid 30009252)
19. Miller EK, Cohen JD. 2001. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 24:167-202. (Pubitemid 32695227)
20. Miner LH, Schroeter S, Blakely RD, Sesack SR. 2003. Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neurol 466:478-494. (Pubitemid 37305993)
21. Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. 2006. Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons. Eur J Neurosci 23:2385-2394. (Pubitemid 43742870)
22. Oropeza VC, Page ME, Van Bockstaele EJ. 2005. Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res 1046:45-54.
23. Oropeza VC, Mackie K, Van Bockstaele EJ. 2007. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res 1127:36-44. (Pubitemid 44854843)
24. Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ. 2007. Repeated cannabinoid administration increases indices of noradrenergic activity in rats. Pharmacol Biochem Behav 86:162-168. (Pubitemid 46274981)
25. Page ME, Oropeza VC, Van Bockstaele EJ. 2008. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neurosci Lett 431:1-5.
26. Pattij T, Wiskerke J, Schoffelmeer AN. 2008. Cannabinoid modulation of executive functions. Eur J Pharmacol 585:458-463.
27. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
28. Pistis M, Ferraro L, Pira L, Flore G, Tanganelli S, Gessa GL, Devoto P. 2002. Delta(9)-tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 948:155-158. (Pubitemid 35283774)
29. Pratt GD, Bowery NG. 1993. Repeated administration of desipramine and a GABAB receptor antagonist, CGP 36742, discretely up-regulates GABAB receptor binding sites in rat frontal cortex. Br J Pharmacol 110:724-735.
30. Ramos BP, Colgan L, Nou E, Ovadia S, Wilson SR, Arnsten AF. 2005. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol Psychiatry 58:894-900. (Pubitemid 41790718)
31. Ranganathan M, D'Souza DC. 2006. The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology 188:425-444. (Pubitemid 44498214)
32. Rudoy CA, Reyes AR, Van Bockstaele EJ. 2008. Evidence for beta(1)-adrenergic receptor involvement in amygdalar corticotropin-releasing factor gene expression: implications for cocaine withdrawal. Neuropsychopharmacology 31:1119-1129.
33. Schneider M, Schomig E, Leweke FM. 2008. Acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats. Addict Biol 13:345-357.
34. Solowij N, Michie PT. 2007. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 32:30-52.
35. Szot P, Ashliegh EA, Kohen R, Petrie E, Dorsa DM, Veith R. 1993. Norepinephrine transporter mRNA is elevated in the locus coeruleus following short- and long-term desipramine treatment. Brain Res 618:308-312. (Pubitemid 23207972)
36. Tanda G, Pontieri FE, Frau R, Di Chiara G. 1997. Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci 9:2077-2085. (Pubitemid 27485240)
37. Tejani-Butt SM, Pare WP, Yang J. 1994. Effect of repeated novel stressors on depressive behavior and brain norepinephrine receptor system in Sprague-Dawley and Wistar Kyoto (WKY) rats. Brain Res 649:27-35. (Pubitemid 24197193)
38. 3H- catecholamines in rat cerebral cortex slices. Naunyn Schmiedebergs Arch Pharmacol 339:293-297.
39. Verrico CD, Jentsch JD, Dazzi L, Roth RH. 2003a. Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. Synapse 48:178-183. (Pubitemid 36520651)
40. Verrico CD, Jentsch JD, Roth RH. 2003b. Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse 49:61-66.
41. Wenzel-Seifert K, Liu HY, Seifert R. 2002. Similarities and differences in the coupling of human beta1- and beta2-adrenoceptors to Gs(alpha) splice variants. Biochem Pharmacol 64:9-20.
42. Zafar HM, Pare WP, Tejani-Butt SM. 1997. Effect of acute or repeated stress on behavior and brain norepinephrine system in Wistar-Kyoto (WKY) rats. Brain Res Bull 44:289-295.
43. Zarate J, Churruca I, Echevarria E, Casis L, Lopez de Jesus M, Saenz del Burgo L, Salles J. 2008. Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: effects of chronic fluoxetine treatment. Brain Res 1236:57-72.